Valuation: Sugentech Inc.

Market Cap 70.71B 50.06M 43.38M 40.61M 37.06M 69.73M 4.77B 70.9M 476M 187M 2.39B 188M 184M 7.97B P/E 2024
-5.35x
P/E 2025 -4.03x
Enterprise Value 40.51B 28.68M 24.85M 23.27M 21.23M 39.95M 2.74B 40.62M 273M 107M 1.37B 108M 105M 4.57B EV / Sales 2024
3.27x
EV / Sales 2025 6.76x
Free-Float
76.84%
Yield 2024 *
-
Yield 2025 -
1 day+0.54%
1 week+17.83%
Current month+21.71%
1 month+21.23%
3 months-26.00%
6 months-29.39%
Current year-24.67%
1 week 4,175
Extreme 4175
4,720
1 month 3,530
Extreme 3530
4,720
Current year 3,530
Extreme 3530
8,170
1 year 3,530
Extreme 3530
8,670
3 years 3,530
Extreme 3530
11,500
5 years 3,530
Extreme 3530
23,750
10 years 3,530
Extreme 3530
65,800
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 25/09/2017
Chief Executive Officer 61 25/09/2017
Director of Finance/CFO 56 30/03/2022
Director TitleAgeSince
Director/Board Member 61 25/09/2017
Director/Board Member 59 25/09/2017
Director/Board Member 50 30/03/2022
Date Insider Type Main position Quantity % Market Cap.
02/04/24 Others 18,730 0.1120%
Change 5-day change 1-year change 3-year change Capi.($)
+0.54%+17.83%-37.92%-40.40% 49.6M
-0.13%+4.70%+29.83%-33.88% 17.28B
+5.67%-5.02%-6.81%+102.62% 1.66B
+0.29%+2.05%-26.95%+24.46% 1B
-0.73%-21.79%-41.84%-82.36% 943M
+0.03%+49.23%+88.95%-11.42% 778M
-0.79%+1.52%-37.18%-51.37% 682M
+5.71%+10.00%-43.74%-46.29% 563M
+0.75%+5.46%-44.70%-43.57% 412M
+1.57%+4.03%-6.30%-21.42% 383M
Average +1.28%+45.22%-12.67%-20.36% 2.38B
Weighted average by Cap. +0.42%+172.66%+18.27%-23.83%

Financials

2024 2025
Net sales 10.1B 7.15M 6.19M 5.8M 5.29M 9.96M 682M 10.12M 68M 26.64M 341M 26.84M 26.25M 1.14B 9.42B 6.67M 5.78M 5.41M 4.93M 9.29M 636M 9.44M 63.41M 24.85M 318M 25.03M 24.48M 1.06B
Net income -15.19B -10.76M -9.32M -8.73M -7.96M -14.98M -1.03B -15.23M -102M -40.09M -513M -40.38M -39.5M -1.71B -23.31B -16.5M -14.3M -13.39M -12.22M -22.99M -1.57B -23.38M -157M -61.51M -788M -61.97M -60.62M -2.63B
Net Debt -48.51B -34.34M -29.76M -27.86M -25.42M -47.83M -3.28B -48.64M -327M -128M -1.64B -129M -126M -5.47B -30.2B -21.38M -18.53M -17.35M -15.83M -29.78M -2.04B -30.28M -203M -79.69M -1.02B -80.28M -78.53M -3.41B
Logo Sugentech Inc.
Sugentech Incorporate is a Korea-based company mainly engaged in the production and sale of in-vitro diagnostic test reagents. The Company is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The Company distributes its products within the domestic market and to overseas markets, including Indonesia.
Employees
144
Date Price Change Volume
10/08/26 4,625.00 +0.54% 102,990
10/08/26 ₩4,600.00 +2.68% 191,200
07/08/26 ₩4,480.00 +2.05% 398,550
06/08/26 ₩4,390.00 -0.57% 125,960
05/08/26 ₩4,415.00 +5.37% 303,725
  1. Stock Market
  2. Stocks
  3. A253840 Stock